Interactions Between Bile Salts, Gut Microbiota, and Hepatic Innate Immunity
- PMID: 28856736
- DOI: 10.1111/imr.12579
Interactions Between Bile Salts, Gut Microbiota, and Hepatic Innate Immunity
Abstract
Bile salts are the water-soluble end products of hepatic cholesterol catabolism that are released into the duodenum and solubilize lipids due to their amphipathic structure. Bile salts also act as endogenous ligands for dedicated nuclear receptors that exert a plethora of biological processes, mostly related to metabolism. Bile salts are actively reclaimed in the distal part of the small intestine, released into the portal system, and subsequently extracted by the liver. This enterohepatic cycle is critically dependent on dedicated bile salt transporters. In the intestinal lumen, bile salts exert direct antimicrobial activity based on their detergent property and shape the gut microbiota. Bile salt metabolism by gut microbiota serves as a mechanism to counteract this toxicity and generates bile salt species that are distinct from those of the host. Innate immune cells of the liver play an important role in the early recognition and effector response to invading microbes. Bile salts signal primarily via the membrane receptor TGR5 and the intracellular farnesoid-x receptor, both present in innate immune cells. In this review, the interactions between bile salts, gut microbiota, and hepatic innate immunity are discussed.
Keywords: FXR; bile salt metabolism; bile salt signaling; bile salt toxicity; innate immunity; microbiota:host interaction.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Bile Acids Activated Receptors Regulate Innate Immunity.Front Immunol. 2018 Aug 13;9:1853. doi: 10.3389/fimmu.2018.01853. eCollection 2018. Front Immunol. 2018. PMID: 30150987 Free PMC article. Review.
-
Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.Hepatology. 2018 Oct;68(4):1574-1588. doi: 10.1002/hep.29857. Epub 2018 May 21. Hepatology. 2018. PMID: 29486523 Free PMC article.
-
Interactions between gut bacteria and bile in health and disease.Mol Aspects Med. 2017 Aug;56:54-65. doi: 10.1016/j.mam.2017.06.002. Epub 2017 Jun 21. Mol Aspects Med. 2017. PMID: 28602676 Review.
-
Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity.Handb Exp Pharmacol. 2019;256:95-108. doi: 10.1007/164_2019_225. Handb Exp Pharmacol. 2019. PMID: 31119464 Review.
-
Cross-talk between bile acids and intestinal microbiota in host metabolism and health.J Zhejiang Univ Sci B. 2015 Jun;16(6):436-46. doi: 10.1631/jzus.B1400327. J Zhejiang Univ Sci B. 2015. PMID: 26055905 Free PMC article. Review.
-
The Role of the Gut Microbiota in Bile Acid Metabolism.Ann Hepatol. 2017 Nov;16(Suppl. 1: s3-105.):s15-s20. doi: 10.5604/01.3001.0010.5494. Ann Hepatol. 2017. PMID: 29080339 Review.
-
Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders.Trends Mol Med. 2015 Nov;21(11):702-714. doi: 10.1016/j.molmed.2015.09.001. Epub 2015 Oct 16. Trends Mol Med. 2015. PMID: 26481828 Review.
-
Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.Gut. 2017 Apr;66(4):620-632. doi: 10.1136/gutjnl-2015-310904. Epub 2016 May 5. Gut. 2017. PMID: 27196572 Free PMC article.
-
The role of bile salts in liver regeneration.Hepatol Int. 2016 Sep;10(5):733-40. doi: 10.1007/s12072-016-9723-8. Epub 2016 Apr 5. Hepatol Int. 2016. PMID: 27048617 Free PMC article. Review.
-
Role of Bile Acids in Metabolic Control.Trends Endocrinol Metab. 2018 Jan;29(1):31-41. doi: 10.1016/j.tem.2017.11.002. Epub 2017 Nov 28. Trends Endocrinol Metab. 2018. PMID: 29195686 Review.
Cited by 9 articles
-
Clinical and microbiological characteristics of patients with biliary disease.World J Gastroenterol. 2020 Apr 14;26(14):1638-1646. doi: 10.3748/wjg.v26.i14.1638. World J Gastroenterol. 2020. PMID: 32327912 Free PMC article.
-
Farnesoid X Receptor Activation Protects Liver From Ischemia/Reperfusion Injury by Up-Regulating Small Heterodimer Partner in Kupffer Cells.Hepatol Commun. 2020 Feb 13;4(4):540-554. doi: 10.1002/hep4.1478. eCollection 2020 Apr. Hepatol Commun. 2020. PMID: 32258949 Free PMC article.
-
Pathogenesis of Nonalcoholic Steatohepatitis: An Overview.Hepatol Commun. 2020 Jan 14;4(4):478-492. doi: 10.1002/hep4.1479. eCollection 2020 Apr. Hepatol Commun. 2020. PMID: 32258944 Free PMC article. Review.
-
First Insight into the Probiotic Properties of Ten Streptococcus thermophilus Strains Based on In Vitro Conditions.Curr Microbiol. 2020 Mar;77(3):343-352. doi: 10.1007/s00284-019-01840-3. Epub 2019 Dec 12. Curr Microbiol. 2020. PMID: 31832842
-
Interplay Between the Host, the Human Microbiome, and Drug Metabolism.Hum Genomics. 2019 Jun 11;13(1):27. doi: 10.1186/s40246-019-0211-9. Hum Genomics. 2019. PMID: 31186074 Free PMC article. Review.
-
Qualitative and Quantitative DNA- and RNA-Based Analysis of the Bacterial Stomach Microbiota in Humans, Mice, and Gerbils.mSystems. 2018 Nov 20;3(6):e00262-18. doi: 10.1128/mSystems.00262-18. eCollection 2018 Nov-Dec. mSystems. 2018. PMID: 30505943 Free PMC article.
-
Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery.Curr Opin Microbiol. 2018 Aug;44:34-40. doi: 10.1016/j.mib.2018.07.003. Epub 2018 Jul 20. Curr Opin Microbiol. 2018. PMID: 30036705 Free PMC article. Review.
-
Mechanisms of NAFLD development and therapeutic strategies.Nat Med. 2018 Jul;24(7):908-922. doi: 10.1038/s41591-018-0104-9. Epub 2018 Jul 2. Nat Med. 2018. PMID: 29967350 Free PMC article. Review.
-
Managing portal hypertension in patients with liver cirrhosis.F1000Res. 2018 May 2;7:F1000 Faculty Rev-533. doi: 10.12688/f1000research.13943.1. eCollection 2018. F1000Res. 2018. PMID: 29780579 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources